Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) ('Highland Copper' or the 'Company' or 'Highland”) is pleased to ...

Ingersoll Rand is expected to unveil its first-quarter results later this month, and analysts are projecting a single-digit ...

Coupang, Inc. will release its first quarter 2026 financial results on Tuesday, May 5, 2026. The release will be available after U.S. market close and an accompanying live webcast will begin at 2:30PM ...

A cultural diplomacy event held in Greece’s capital, Athens, brought together scholars, diplomats, and cultural figures to denounce the deliberate targeting of Iran’s historical and cultural heritage ...

Nextpower (Nasdaq: NXT) will announce its fourth quarter fiscal 2026 and full-year financial results after the market closes on Tuesday, May 12, 2026. The company will hold a conference call to ...

Ongoing production scale orders from U.S. Tier-1 customer accelerate as drones are delivered under a $249 million Program of Record Deliveries have already commenced and are expected to conclude well ...

TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will ...

AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in AI data protection, unifying data security, governance, and resilience, will report its first quarter 2026 financial results after the US ...

Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer, autoimmune, and neuroimmune diseases, today announced the appointment of M ...

It may look like a cute little dolphin-themed toy, but the Flipper Zero is a surprisingly powerful learning tool for hacking.

Good morning, and welcome to Washington Trust Bancorp, Inc's Conference Call. My name is Elliot, and I'll be your operator today. [Operator Instructions] As a reminder, today's call is being recorded.

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies – outcomes not previously observed in SPS ...